Cardiac MRI for Tricuspid Regurgitation
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this research is to assess the severity of tricuspid regurgitation (a disorder in which the tricuspid valve in the heart does not close tight enough) using cardiac magnetic resonance imaging (MRI).
Who Is on the Research Team?
Mohamad Alkhouli, MD
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for individuals with moderate or severe tricuspid regurgitation, which is when the heart's tricuspid valve doesn't close properly. Participants must not have a pacemaker/defibrillator that interferes with MRI, any prior tricuspid valve replacements, planned surgery on the tricuspid valve, or primary liver disease.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Imaging Assessment
Participants undergo cardiac magnetic resonance imaging (CMR) and magnetic resonance elastography (MRE) with contrast to assess tricuspid regurgitation severity and associated abnormalities.
Follow-up
1-year follow-up conducted via phone to inquire about patient's vital status, symptoms, and hospitalizations.
What Are the Treatments Tested in This Trial?
Interventions
- Cardiac Magnetic Resonance
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor